Sars-cov-2 vaccines
US-2024408193-A1 · Dec 12, 2024 · US
Truncated L1 protein of human papillomavirus type 11
US9533035B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9533035-B2 |
| Application number | US-60198308-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 29, 2008 |
| Priority date | May 29, 2007 |
| Publication date | Jan 3, 2017 |
| Grant date | Jan 3, 2017 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The invention relates to a truncated L1 protein of the Human Papillomavirus Type 11, a virus-like particle consisting of the protein, a vaccine comprising said virus-like particle, and the use of the vaccine in the prevention of condyloma acuminatum or HPV infections.
First claim
Opening claim text (preview).
The invention claimed is: 1. A vaccine for prevention of condyloma acuminatum or HPV infections, comprising vaccine A or vaccine B: wherein the vaccine A comprises: (A1) HPV11 VLP comprising a protein consisting of the amino acid sequence set forth in SEQ ID NO: 1; (A2) HPV6 VLP comprising a protein consisting of the amino acid sequence set forth in SEQ ID NO: 7; and (A3) carriers or excipients useful for vaccines; and wherein the vaccine B comprises: (B1) HPV11 VLP comprising a protein consisting of the amino acid sequence set forth in SEQ ID NO: 1; (B2) HPV6 VLP comprising a protein consisting of the amino acid sequence set forth in SEQ ID NO: 7; (B3) HPV16 VLP comprising a protein consisting of the amino acid sequence set forth in SEQ ID NO: 8; (B4) HPV18 VLP comprising a protein consisting of the amino acid sequence set forth in SEQ ID NO: 9; and (B5) carriers or excipients useful for vaccines. 2. The vaccine as claimed in claim 1 , wherein the vaccine comprises the HPV6 VLP and the HPV11 VLP. 3. The vaccine as claimed in claim 2 , wherein the vaccine comprises a combination of the HPV6 VLP, the HPV11 VLP, the HPV 16 VLP and the HPV 18 VLP. 4. A method for preventing condyloma acuminatum or HPV infections, comprising administering a vaccine comprising a preventively effective amount of the vaccine according to claim 1 , to an individual in need of preventing condyloma acuminatum or HPV infections.
Assignees
Inventors
Classifications
for DNA viruses · CPC title
Drugs for genital or sexual disorders (for disorders of sex hormones A61P5/24); Contraceptives · CPC title
Keratolytics, e.g. wart or anti-corn preparations · CPC title
Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof (preparing medicinal viral antigen or antibody compositions, e.g. virus vaccines, A61K39/00) · CPC title
- A61K39/12Primary
Viral antigens · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9533035B2 cover?
- The invention relates to a truncated L1 protein of the Human Papillomavirus Type 11, a virus-like particle consisting of the protein, a vaccine comprising said virus-like particle, and the use of the vaccine in the prevention of condyloma acuminatum or HPV infections.
- Who is the assignee on this patent?
- Zhang Jun, Wang Jin, Yang Chunyan, and 5 more
- What technology area does this patent fall under?
- Primary CPC classification A61K39/12. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Jan 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).